How many studies have been conducted on Lymphocyte Function Associated Antigen 1?

BiohacksAI has indexed 299 PubMed studies on Lymphocyte Function Associated Antigen 1, including 2 randomized controlled trials (RCTs). 16% of studies involve human subjects.

What are the main research areas for Lymphocyte Function Associated Antigen 1?

The primary research domains for Lymphocyte Function Associated Antigen 1 are 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

Lymphocyte Function Associated Antigen 1

An integrin heterodimer widely expressed on cells of hematopoietic origin. CD11A ANTIGEN comprises the alpha chain and the CD18 antigen (CD18 ANTIGENS) the beta chain. Lymphocyte function-associated antigen-1 is a major receptor of T-CELLS; B-CELLS; and GRANULOCYTES. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by NATURAL KILLER CELLS and granulocytes. Intracellular adhesion molecule-1 has been defined as a ligand for lymphocyte function-associated antigen-1.

299+ PubMed studies analyzed · 2 RCTs · Evidence Score: 41.8

Research Domains

Lymphocyte Function Associated Antigen 1 has been studied across 15 research domains including 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation, 🫁 Liver & Detox, 🦴 Bone & Joint. The primary research focus is 🛡️ Immunity with 22% of studies addressing this area.

Loading evidence profile...

This evidence profile for Lymphocyte Function Associated Antigen 1 is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.